Chendu DIAO Pharmaceutical Group CO., LTD.
Chendu DIAO Pharmaceutical Group CO., LTD.
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Mass Balance Study of [14C]DA-302168S in Healthy Chinese Adult Male Participants | Healthy Adult Subjects | Not yet recruiting | Phase 1 | 2026-10-05 | NCT07857265 | |
| A Study to Evaluate the Efficacy and Safety of DA-302168S Tablets in Subjects With Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Not yet recruiting | Phase 2 | 2026-08-31 | NCT07755150 | |
| A Study of DA-302168S in Participants With Overweight/Obesity | Body Weight, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, nutritional disorder, obesity disorder, overnutrition | Recruiting | Phase 3 | 2026-08-06 | NCT07629544 |